First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
18.16
-0.84 (-4.42%)
At close: Apr 24, 2026, 4:00 PM EDT
18.20
+0.04 (0.22%)
After-hours: Apr 24, 2026, 7:57 PM EDT
TRAX Market Cap
TRAX has a market cap or net worth of $631.04 million as of April 24, 2026.
Market Cap
631.04M
Enterprise Value
333.51M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.16
Market Cap Chart
Since April 6, 2026, TRAX's market cap has decreased from $660.23M to $631.04M, a decrease of -4.42%. That is a compound annual growth rate of -60.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 631.04M | -4.42% |
| Apr 23, 2026 | 660.23M | 0.69% |
| Apr 22, 2026 | 655.71M | 11.00% |
| Apr 21, 2026 | 590.73M | -8.60% |
| Apr 20, 2026 | 646.33M | -17.37% |
| Apr 17, 2026 | 782.20M | -11.38% |
| Apr 16, 2026 | 882.62M | 3.46% |
| Apr 14, 2026 | 853.08M | 3.37% |
| Apr 13, 2026 | 825.28M | 1.06% |
| Apr 10, 2026 | 816.60M | 2.17% |
| Apr 9, 2026 | 799.22M | -4.96% |
| Apr 8, 2026 | 840.92M | 27.37% |
| Apr 7, 2026 | 660.23M | - |
| Apr 6, 2026 | 660.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 766.59M |
| Cullinan Therapeutics | 765.66M |
| Relmada Therapeutics | 743.66M |
| Alpha Tau Medical | 712.88M |
| Tenax Therapeutics | 708.73M |
| Lexicon Pharmaceuticals | 703.31M |
| BridgeBio Oncology Therapeutics | 701.89M |
| Gyre Therapeutics | 698.76M |